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Abstract
HIV-1 escape from the cytotoxic T-lymphocyte (CTL) response leads to a weakening of viral control and is likely to be
detrimental to the patient. To date, the impact of escape on viral load and CD4
+ T cell count has not been quantified,
primarily because of sparse longitudinal data and the difficulty of separating cause and effect in cross-sectional studies. We
use two independent methods to quantify the impact of HIV-1 escape from CTLs in chronic infection: mathematical
modelling of escape and statistical analysis of a cross-sectional cohort. Mathematical modelling revealed a modest increase
in log viral load of 0.051 copies ml
21 per escape event. Analysis of the cross-sectional cohort revealed a significant positive
association between viral load and the number of ‘‘escape events’’, after correcting for length of infection and rate of
replication. We estimate that a single CTL escape event leads to a viral load increase of 0.11 log copies ml
21 (95%
confidence interval: 0.040–0.18), consistent with the predictions from the mathematical modelling. Overall, the number of
escape events could only account for approximately 6% of the viral load variation in the cohort. Our findings indicate that
although the loss of the CTL response for a single epitope results in a highly statistically significant increase in viral load, the
biological impact is modest. We suggest that this small increase in viral load is explained by the small growth advantage of
the variant relative to the wildtype virus. Escape from CTLs had a measurable, but unexpectedly low, impact on viral load in
chronic infection.
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Introduction
The CTL response is thought to play a role in firstly reducing
[1,2] and then controlling the level of HIV-1 viraemia. Evidence for
the protective role of CTLs in humans includes HLA class I
heterozygous advantage [3], the evolution of multiple viral
mechanisms to evade CTL surveillance [4–6] and the observation
of statistically significant associations between possession of certain
HLA class I alleles and the rate of disease progression [7] although
the size of this CTL-mediated protective effect is contentious [8–
10]. The pressure exerted by CTLs on HIV-1 leads to frequent
[11,12]selection of HLAclass I-associated viralpolymorphisms that
result in reduced or abolished CTL recognition, a phenomenon
known as HIV-1 ‘‘escape’’ from the CTL response [11,13–17]. It
seems likely that HIV escape would be detrimental for the host, yet
the impact of escape on viral load or CD4
+ T-cell count is unclear.
Longitudinal studies following viral escape in HIV-1 infected
individuals have shown no conclusive results [18–21], largely
because of data scarcity. Cross-sectional studies show a relationship
between HLA-associated polymorphisms in pol and high viral load
[11], and between HLA-associated polymorphisms in gag and low
CD4
+ count [22] and high viral load [23]. However, as
acknowledged by the authors themselves [23], it is impossible to
interpret these results because the direction of causality is unknown.
That is to say, it is unclear whether the negative correlation between
the number of viral polymorphisms and CD4
+ T-cell count arises
because a high number of polymorphisms leads to poor CTL
control and greater immunosuppression, or simply because these
individuals have been infected for a longer time, resulting in a lower
CD4
+ T-cell count and, simultaneously, a greater opportunity to
develop mutations. Similarly, the association between high viral
loadandHLA-associatedpolymorphismsmaybeduetoviralstrains
escaping the immune response which results in an increase in viral
load, or it may be that high viral load and high viral replication
allows for more mutations to accumulate. Furthermore, recent work
demonstrated a correlation between rate of progression to AIDS
and the replication rate of the infecting strain [24,25]. This
introduces another potential confounding factor into associations
between HLA-associated polymorphisms and surrogate markers of
disease progression. Therefore, in order to interpret the relation-
ships between HLA-associated polymorphisms and viral load and/
or CD4+ count, it is essential to adjust for the number of mutation
events that have occurred in individuals.
Hence, because of limited longitudinal data and difficulties in
interpreting cross-sectional data, the consequences of HIV-1
escape from the CTL response are still unclear. The aim of this
work was to quantify the impact of HIV escape on viral load in
chronic infection.
Results
Predicted increase in viral load upon escape is modest
We used an extension of the Perelson/De Boer model of HIV-1
dynamics [26] to simulate the outgrowth of an HIV-1 variant
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to check our intuition that escape must lead to an increase in viral
load; secondly, to obtain an order of magnitude estimate of the
predicted increase in viral load upon escape; and thirdly, to test
whether a small increase in viral load upon escape could be
explained solely by the outgrowth rate of the variant, or whether it
was necessary to postulate additional mechanisms (e.g. the
generation of de novo CTL responses which recognise the variant
and subsequently reduce viral load).
The variant was assumed to have reduced replicative ability
compared to the wildtype (i.e. although the variant is fitter in the
presence of a CTL response, it is less fit in the absence). The
system was modelled under the ‘‘worst case’’ scenario that the
CTL response is unable to target the escaped epitope again and so
does not regain control of viraemia. In all 100,000 runs of the
model, covering a wide range of biologically plausible parameters,
there was an increase in viral load upon escape. The increase in
viral load upon escape was significantly correlated with the
outgrowth rate of the variant (Spearman’s rank correlation:
p,0.0001; rho=0.59). For outgrowth rates representative of what
is observed in chronic HIV infection (i.e. the variant replaces the
wildtype at rate 0.01–0.04 per day, corresponding to variant
outgrowth in 230–900 days [4,8,13,15,16,20,27–31]), the median
increase in viral load was 0.051 log copies ml
21 (95% confidence
interval: 0.050–0.052; Figure 1; Figure S1).
A second scenario, in which the infection and virion production
rates of the variant were set independently of the wildtype such
that the variant was permitted to be fitter than the wildtype at the
time of escape, was also considered. In this model, the median
increase in viral load was 0.050 log copies ml
21 (95% confidence
interval: 0.044–0.056). Even if the outgrowth rate of the escape
variant was an order of magnitude higher (e.g. 0.4 per day,
corresponding to the variant replacing the wildtype in 23 days), the
median predicted increase in viral load was still only 0.27 log. As
before, there was a significant positive correlation between the
outgrowth rate of the escape variant and the resulting increase in
viral load (Spearman’s rank correlation: p,0.0001; rho=0.59).
Interestingly, for this model there was a fraction (12%) of cases in
which escape resulted in a decrease in viral load.
To test the robustness of the prediction that escape leads to a
small increase in viral load, additional mathematical models were
simulated which tested different assumptions and explicitly
modelled the CTL response as a separate dynamic population
(see Table S1 for further details). Median changes in viral load for
these models ranged from an increase of 0.017 to 0.037 log copies
ml
21 (see Text S1 for full details).
Relationship between number of ‘‘escape events’’ and
viral load in a chronically infected cohort
Following Moore et al. [11] and Kiepiela et al. [32], we define an
‘‘escape event’’ as a coding change in an epitope that is statistically
significantly associated with possession of the restricting HLA
allele. We introduce two differences into our analysis. Firstly, we
cap the number of escape events per epitope at 1 (so that we do not
double-count additional mutations required for escape from the
same CTL clone). Secondly and more importantly, we adjust for
the background level of mutation. Variation in the length of
infection and viral replicative rates between individuals are
confounding effects which can increase both the number of
mutations and viral load making it impossible to infer the impact
of HIV escape on viral load simply by studying raw cross-sectional
data [22].
In order to correct for the background level of mutation, we
performed multivariate regression. This allowed us to test whether
the number of escape events (NEE) is a significant independent
predictor of viral load after a possible relationship between viral
load and the background level of mutation (quantified by NSE, the
number of synonymous changes in epitopes per individual) had
been taken into account.
The analysis showed that the number of escape events is a
significant independent predictor of log viral load when the
number of synonymous changes is taken into account (Figure 2,
multiple linear regression: two-tailed p=0.0021, gradient=0.11,
r
2=0.060; Figure S2 shows alternative representations; linear
regression of NEE alone on log viral load: p=0.029, gradi-
ent=0.055). Neither changing the definition of ‘‘escape event’’ to
include only mutations with a decrease in predicted binding
affinity (multiple linear regression: p-value=0.42, gradient=0.13;
see Text S1), nor stratifying the cohort based on frequently
occurring alleles (see Table S2), altered these results. Repeating
this analysis with CD4+ T-cell count and the number of escape
events showed a trend toward a negative association (multiple
linear regression: two-tailed p=0.062, gradient=223).
In order to investigate the relationship between escape from
protective alleles and viral load, we performed three analyses.
First, we removed individuals with protective alleles from the
multiple linear regression (see Table S2). The ‘‘unprotected’’
group still has a statistically significant positive association between
log viral load and NEE (multiple linear regression p=0.00024,
coef=0.19), although no association was observed in the
‘‘protected’’ group (p=0.20, coef=0.060). Second, we added
the number of protective alleles and the number of not-protective
alleles possessed by an individual as (two) additional predictors of
log viral load to the multiple linear regression. We find that all four
factors are significant independent predictors of log viral load
(multiple linear regression: NEE p=0.000444, coef=0.12038;
NSE p=0.009526, coef=20.09110; Protective p=0.006509,
coef=20.47809; Not-protective p=0.006715, coef=0.28016).
Third, we wanted to further explore whether alleles associated
with a lower viral load were protective because they presented
epitopes where escape was rare. To do this we calculated the NEE
of epitopes presented by protective alleles by individual and
compared it to the NEE of epitopes presented by not-protective
alleles. To ensure equal sample size in the ‘‘protective’’ and ‘‘not-
protective’’ groups, we selected a number of alleles in either group
such that 10% of the cohort possessed a protective allele, and 10%
Author Summary
HIV, like many viruses, has evolved multiple strategies to
evade immune surveillance. One of these strategies is the
evolution of escape mutations which reduce the ability of
the immune response to kill HIV-infected cells. But does
HIV escape matter? Some believe that the accumulation of
escape mutations leads to AIDS; many more believe
escape is likely to be highly detrimental to human health.
Yet, to date, it has not been possible to measure the
impact of escape. We developed two independent
methods to quantify the impact of escape on HIV viral
load. Both methods showed that escape does lead to a
detectable increase in viral load, but is unlikely to have a
major impact on patient health as the increase is small.
Indeed, only 6% of between-individual variation in viral
load could be attributed to HIV escape. This work suggests
that the current research focus on escape in chronic HIV
infection might be out of proportion to its importance
with other factors playing a more significant role in
determining viral load.
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epitopes restricted by protective HLA alleles had a median of 1.0
additional escape events than not-protective alleles (Wilcoxon rank
sum test: p=0.013, difference=1.0). These three pieces of analysis
show that escape in epitopes presented by not-protective HLA
class I alleles is detrimental for the host, and that protective HLA
class I alleles do not have fewer escape events than ‘detrimental’
alleles. The ‘‘protectiveness’’ of an allele is therefore not
attributable to an inability to escape such responses.
To check for robustness, we performed a bootstrap analysis by
sampling 10,000 times with replacement from the Full cohort. We
found that 92% of the bootstrap runs resulted in a significant
positive association between log viral load and the number of
escape events, the median two-tailed p-value of all runs was 0.0019
(95% confidence interval: 0.0018–0.0021; Figure S3A).
Quantifying the impact of an ‘‘escape event’’ on viral load
By calculating the gradient of the line of best fit through the
data, after correcting for the background level of mutation, we find
that each escape event causes a median increase in viral load of
0.11 log copies ml
21 (95% confidence interval: 0.040–0.18), or an
absolute median increase of 8,500 copies ml
21. Overall, the
number of escape events could only explain about 6% of the
variation in viral load in the cohort.
Mutations in pol account for the majority of the impact
of escape on viral load
Next we investigated whether escape events in any particular
gene were associated with the increase in viral load, so we repeated
the multi-linear analysis on each gene independently (Figure 3;
Table S3). We found a significant positive association between log
viral load and coding changes in pol (multiple linear regression:
two-tailed p-value=0.0059, gradient=0.14), but not in any other
gene. Additionally, a significant positive association was found
between viral load and escape events in pol in 83% of bootstrap
runs (Figure S4 and Table S4). Amongst the other genes, we noted
that there was a decrease in log viral load with escape events in
gag, although this was not statistically significant (multiple linear
regression: two-tailed p-value=0.91, gradient=20.011; Table
S3). As Gag-specific CTL responses have been shown as protective
[33–37], we had expected escape to lead to a large rise in viral
load. To check that power was not an issue, we repeated the
analysis using a longer HLA-gag epitope list derived using a
phylogenetically corrected method [38]. This confirmed the
negative association between escape events in gag and log viral
load (multiple linear regression: two-tailed p-value=0.013,
gradient=20.091).
Next, we investigated which gene (or genes) was driving the
effect in the 92% of bootstrap runs that gave a significant
association between the total number of escape events in all genes
and viral load (see previous section ‘‘Relationship between number
of escape events and viral load’’). This analysis showed that escape
events in most genes were detrimental for the host, but that escape
events in Pol epitopes were most frequently (81%) behind the
increase in viral load (Table S5).
Finally, we investigated individual gene effects in the Extended
cohort (N=347) in order to increase power. We could not study
this cohort in the previous analysis as we did not have sequence
Figure 1. Predicted increase in viral load per escape event as a function of the outgrowth rate of the escape variant. Results from the
first 1,000 runs from the mathematical model are plotted. The increase in viral load after an escape event is significantly positively correlated with the
outgrowth rate (k) of the escape variant (Spearman’s rank correlation: p,0.0001, rho=0.59). The median predicted increase in viral load for observed
values of the outgrowth rate (k, shaded area) is approximately 0.051 log (95% confidence interval: 0.050–0.052).
doi:10.1371/journal.pcbi.1000981.g001
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Number of escape events is a significant predictor of log viral load after the background level of mutation is taken into account (multiple linear
regression: p=0.0021, gradient=0.11, r
2=0.060, N=157). The width of each bar is proportional to the number of points. Alternate representations of
this data are shown in Figure S2.
doi:10.1371/journal.pcbi.1000981.g002
Figure 3. The number of escaped events (NEE) against log viral load, corrected by the number of synonymous epitopes (NSE),
stratified by gene. Data used in Figure 2 was stratified by each HIV gene and the multiple linear regression repeated. Only escape events in pol
were statistically significant independent predictors of log viral load (p=0.0059, gradient=0.14, line of best fit drawn), escape events in all other
genes were not significant (data not plotted for genes nef, rev, vif and vpr, see Table S3).
doi:10.1371/journal.pcbi.1000981.g003
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the purposes of individual gene analysis. As the Full cohort is a
subset of the Extended cohort, the results must not be considered
independent. Analysis of this extended cohort strengthened and
extended our previous results. Escape events in pol were still
significantly associated with an increase in viral load (at a more
significant two-tailed p-value of 0.0032). The results of a bootstrap
run on this extended cohort are shown in Figure 4. Genes appear
to fall in one of two distinct groups: genes in which escape events
were associated with a high viral load (env, nef, pol and vif) and genes
in which escape events were associated with a low viral load (gag
and rev).
Discussion
To date, it has not been possible to quantify the impact of HIV-
1 escape on viral load. Longitudinal datasets are too sparse to
allow firm conclusions and studies of cross-sectional datasets have
been impossible due to confounding factors. Furthermore,
previous studies [39–41] have concentrated on escape from CTLs
associated with protection, e.g. Gag-specific CTLs, or on
protective alleles, e.g. B*57, which although interesting and
important for determining mechanisms of protection, are unlikely
to be representative and may give a distorted view of the
importance of escape. Here, we have investigated the impact of
‘‘typical’’ (i.e. average) escape events in seven genes in chronic
HIV-1 infection using two independent methods: mathematical
modelling and cross-sectional cohort analysis, using multiple
regression to remove confounding factors.
Firstly, we simulated the emergence of HIV-1 escape variants
using an extension of the Perelson/De Boer model of HIV-1
dynamics [26], using parameters selected from a wide range of
biologically realistic values. We modelled the system under the
‘‘worst case scenario’’ that the CTL response does not regain
control of viraemia following escape. This modelling showed that
the increase in viral load per escape event was significantly
positively correlated with the outgrowth rate of the variant
(Spearman’s rank correlation: p,0.0001; rho=0.59). The median
increase in viral load was 0.051 log copies ml
21 per escape event.
Adapting the model to allow CTLs to partially regain control
would lead to a smaller long-term increase in load per escape
event. A range of alternative models based on different
assumptions led to similar conclusions.
Secondly, we analysed a cross-sectional cohort of 157 HIV-1 C-
clade infected individuals. We used a novel method to remove
confounding factors which permits the analysis of data-rich cross-
Figure 4. Bootstrap distribution of one-tailed p-values from multiple linear regression of each gene in the K37 epitope list. Subjects
were sampled with replacement 10,000 times from the Extended cohort (N=347). The shaded area on the left-hand side of each graph indicates the
proportion of runs with a statistically significant increase in log viral load (one-tailed p#0.025), and the shaded area on the right indicates a significant
decrease in log viral load (one-tailed p$0.975). In each panel the median change in log viral load associated with an escape event in that gene is
presented.
doi:10.1371/journal.pcbi.1000981.g004
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accrued by an individual as a clock that keeps count of the number
of ‘‘mutation events’’, we corrected for differences in individual
mutation rates, regardless of whether the increased mutation
frequency resulted from a higher viral set point, higher viral
replication rate or longer length of infection (and hence lower
CD4+ count). We show a statistically significant positive
association between the number of mutated epitopes and viral
load. We found a small increase in viral load of 0.11 log per escape
event. To put this into context, the median standard deviation of
random fluctuations in log viral load over time in a chronically
HIV B-clade infected cohort is 0.32 (see Text S1). The association
between the number of mutated epitopes and viral load was
mainly accounted for by mutations in pol. The escape events
studied could have occurred at any time point prior to sampling,
i.e. evolved during the acute [42] or chronic phases, or were
already present in the transmitted infecting virus.
The small increase in viral load per escape event that we
observed in the cohort could be explained by two (non-exclusive)
hypotheses. Firstly, the impact of escape on viral load is transient
due to the flexibility of the CTL response which adapts to
recognise either the escape variant or a previously sub-dominant
epitope, resulting in renewed and long-term suppression of viral
load. Secondly, the impact of escape is small because the variant
has a slow outgrowth rate (i.e. a small net fitness advantage
compared with the wildtype), so the accompanying increase in
viral load is not large. Under the first hypothesis, escape initially
causes a large increase in viral load but then the CTL response
adapts and partially regains control of viraemia, either by targeting
previously unrecognised or sub-dominant epitopes [16,43,44] or
by developing a new CTL response against the variant in the case
of escape due to loss of TCR recognition [45]. The transient
nature of the increase would unlikely be reflected in a cross-
sectional study, and so the observed increase in viral load would be
small. Under the second hypothesis, the increase in viral load per
escape event is small simply because the outgrowth rate of the
escape variant is slow (i.e. CTL selection pressure on the wildtype
minus fitness cost of the variant is small). The mathematical
modelling we performed allowed us to test these two hypotheses.
For outgrowth rates observed in chronic HIV-1 infection
[4,13,15,16,20,27–31], equivalent to a variant replacing the
wildtype in 230 to 900 days from first appearance of the variant,
we found that the median increase in viral load was predicted to be
around 0.051 log copies ml
21. Whilst we do not rule out that
existing CTL responses are strengthened or that new CTL
responses can arise to regain control of viraemia after an escape
event, this mechanism is unnecessary to explain the observed
modest increase in viral load per escape event. Rather, the small
increase in viral load is exactly what would be predicted given the
observed outgrowth rate of escape variants in late primary and
chronic infection.
Additionally, the modelling showed that the increase in viral
load per escape event was significantly positively correlated with
the outgrowth rate of the variant: that is, the faster the variant
outgrows the wildtype, the larger the resulting increase in viral
load. This is consistent with the observation that protective HLA
class I alleles associated with slow progression to AIDS tend to
present epitopes where escape variants have a slower outgrowth
rate [46]. These two observations predict, somewhat counter-
intuitively, that escape from protective HLA alleles will result in a
smaller increase in viral load than escape from non-protective
alleles.
A similar argument could explain our finding that escape events
in gag did not cause a measurable increase in viral load. Given the
protective role of Gag-specific CTLs [33–37], it might be expected
that escape from these CTLs would be particularly detrimental.
However, some escape variants in gag have also been shown to
carry very heavy fitness costs [47–49]. Consequently, the
outgrowth rate of escape variants in gag will not necessarily be
fast. In fact, recent preliminary data suggests the opposite: that
escape variants in gag have a significantly slower outgrowth rate
than variants in other proteins [46]. This would explain why
escape mutations in gag have not been found to lead to large
increases in viral load. Results from the modelling suggest one
potential mechanism how escape can lead to a lower viral load.
Intuitively, we would expect that variants must have a net fitness
advantage over the wildtype, which results in a higher viral load
upon escape. However, in Model 2, we observed that 12% of all
runs resulted in a decrease in viral load and the outgrowth of the
variant. Our analysis of these runs showed that in all cases, the
variant was more infectious than the wildtype (higher b9) but able
to produce fewer virions (lower h9), resulting in an increase in the
number of variant-infected cells but not an increase in the viral
load. This intriguing result suggests that although the variant has a
net fitness advantage over the wildtype, it may only be manifest at
the level of infected cells and not necessarily at the level of free
virus. It is therefore not unfeasible for an ‘attenuated variant’ to
emerge. A prediction of the model is that proviral load would
always be higher after escape. Alternatively, the negative
association between escape events in gag and viral load may
simply be due to individuals with protective HLA class I alleles,
which are associated with lower viral load, mounting more Gag-
specific CTL responses and therefore the emergence of more
escape variants in gag.
A number of studies have reported a relationship between
protective HLA class I alleles and low levels of viral escape,
suggesting that escape is an important determinant of progression
to AIDS [46,50–52]. However, we did not find any evidence that
protective HLA class I alleles were associated with lower levels of
viral escape. Instead, we observed that individuals possessing a
protective allele had more escape events than individuals with an
allele associated with a higher viral load. The protectiveness of an
allele therefore appears unrelated to its ability to prevent viral
escape (despite the high fitness cost of escape mutations), but
rather suggests that protective alleles present epitopes where
variants only have a small net fitness advantage.
We find that escape only determines approximately 6% of
variation in viral load. How can we reconcile the low impact of
escape events on viral load with disease progression, given the
strong association between HLA and disease progression? As viral
load is subject to high levels of random fluctuations within an
individual over time, one possible explanation is that viral load is
not always strongly associated with progression [53]. However, we
also failed to find a strong association between escape events and
CD4
+ T cell count, which is usually a better correlate of
progression. Another possible explanation is that HLA-mediated
protection may not be completely dependent on CTL, as other
HLA-mediated factors could play a greater role in HIV infection,
e.g. NK cells or linkage disequilibrium with a protective gene. It is
therefore entirely plausible that CTL escape only partially
contributes to HLA-mediated protection. Furthermore, a much
greater number of CTL-independent factors potentially determine
viral load, for example, CCR2 polymorphisms and CCR5
deletions [54–56], Nef deletions [57], NK cell receptor polymor-
phism [58], viral tropism [59] and host activation status [60]. A
recent study also showed significant genetic and immunological
heterogeneity between people who naturally control HIV-1
viremia [33]. Other studies have estimated that HLA class I type
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escape mutations determine about 30% of HLA class I protection
[46]. If we assume in the most extreme case that that HLA-
associated protection is solely due to the ability to target epitopes
where escape is rare, then this would indicate that only around
{3%–15%}630%=0.9% to 4.5% of variation in viral load could
be explained by escape, which is very similar to our estimate of
6%. Given the large number of possible determinants of viral load
it is perhaps not surprising that HIV escape from CTL can only
explain a small proportion of an individual’s viral load.
We predicted mathematically and also showed by analysis of an
HIV-1 infected cohort that HIV escape from the CTL response is
associated with a small increase in viral load. Although the finding
that a typical escape event has a modest impact on viral load is
surprising, it is consistent with firstly, the failure to find a clear
association between escape and viral load in longitudinal studies
[18–21], secondly, the low outgrowth rate of escape variants in
chronic infection [8], and lastly, the weak positive correlation
between uncorrected viral load and HLA-associated polymor-
phisms in gag observed by Brumme et al. [23].
This study shows that although the impact of HIV-1 escape
from CTLs is highly statistically significant, the effect in clinical
terms is mild: an increase in viral load of 0.11 log copies ml
21 will
have few consequences for patient health [64]. This unexpected
result demands further independent studies to corroborate it. If
replicated, this result would suggest that, with the crucial exception
of vaccine design, the focus on HIV escape may be out of
proportion to its importance with other factors playing a more
significant role in determining viral load in chronic HIV-1
infection.
Materials and Methods
Mathematical model of viral escape
The Perelson/De Boer model of HIV-1 dynamics [26] was
adapted to include HIV-1 escape variants, which have escaped a
single CTL response (Equation 1).
_ S S~l{dS{bSW{b’SV
_ X X~bWS{bX{cX
_ W W~hX{uW
_ Y Y~b’VS{bY
_ V V~h’Y{uV
ð1Þ
The five populations (all measured per mm
3) are as follows:
uninfected CD4
+ cells (S); CD4
+ cells infected with wildtype virus
(X); free wildtype virus (W); CD4+ cells infected with variant virus
(Y); free variant virus (V). Parameters are described in Table 1.
The model was simulated using lsoda in R. Each run sampled
parameters from ranges obtained from the literature [65–71], and
the variant was assumed to be attenuated compared to the
wildtype, such that b.b9 and h.h9. The median outgrowth rate
of the variant (k, see below) observed in chronic HIV-1 infection
[4,13,15,16,20,27–31] is 0.01 d
21 to 0.04 d
21 [8]; we were
interested in typical escape events and so runs with an outgrowth
rate outside this range were not included in the analysis and the
model was run until 100,000 simulations had been accumulated.
From these runs the difference in viral load of the wildtype (W+V
at t0) and the variant (W+Va tt end) was calculated. A full
description of this model, as well as other models considered, can
be found in Text S1.
Definition of k: The outgrowth rate
The outgrowth rate (net growth advantage) of an escape variant
is the rate at which the variant outgrows the wildtype virus. It is
defined as the growth rate of the variant minus the growth rate of
the wildtype [8,72], or: (variant replication rate – variant death
rate) – (wildtype replication rate – wildtype death rate). As this
quantity is not easily expressed in terms of the model parameters,
we use the results of the model simulation and Equation 2 to
calculate the outgrowth rate of the variant.
k~net growth rate of variant virus infected cells{
net growth rate of wildtype infected cells
&
b’VavgSavg
Yavg
{
bYavg
Yavg
  
{
bWavgSavg
Xavg
{
bXavg
Xavg
{
cXavg
Xavg
  
&cz
b’Vavg
Yavg
{
bWavg
Xavg
  
Savg
ð2Þ
Vavg is the average value of variant free virus (V) from the time
when the variant first emerges (t0) to the time when the variant
constitutes 99% of the virus population (tfix). Similar to Asquith et
al. [8], we do not consider the time for the variant to emerge when
calculating the outgrowth rate. Xavg (average number of wildtype-
infected cells), Wavg (wildtype free virus), Yavg (variant-infected cells)
and Savg (uninfected cells) are similarly defined as in Equation 3.
Vavg~
Ð
tfix
t0
Vdt
tfix{t0
ð3Þ
Alternatively, k can be estimated by fitting the solution of a
simplified model of escape virus dynamics [8] to the model data
using nonlinear least-squares regression (using the Levenberg-
Marquardt algorithm, nls.lm, in the minpack.lm package in R). The
two approaches to calculating k are in strong positive agreement
(Pearson’s product moment correlation coefficient: p,0.0001,
r=0.998). The time for the variant to reach fixation is given by
approximately 9/k (see Text S1 for details).
K37 HLA-epitope list
This list, reproduced in Table S6, is taken from Supplementary
Table S3 of Kiepiela etal.2007 [73], and consists of 37 HLA-epitopes
pairs which are statistically significantly associated with coding
changes in the epitope region (plus three amino acidseither side of the
epitope region) in individuals with the same HLA class I allele.
Durban cohort: Full and Extended
Viral RNA sequence, HLA class I genotype and viral load were
taken from a treatment naı ¨ve HIV-1 C-clade infected cohort
attending a prenatal clinic in Durban, as described in [32].
Individuals with a viral load greater than 10
6 copies ml
21 were
classed as acutely infected [74,75] and removed from the analysis.
This cohort consisted of two overlapping groups: the Full cohort
which consisted of individuals with virus sequence data for all
epitopes in the K37 epitope list (N=157); and the Extended
cohort which included all individuals with complete viral sequence
data for a single gene (N=347). The Extended cohort includes all
individuals in the Full cohort. All cohort data was collected and
anonymised by researchers external to the authors of this paper.
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Following Moore et al. [11] and Kiepiela et al. [32], a viral
coding change is classed as a ‘HLA-associated polymorphism’ if
the variant amino acid is significantly associated with possession of
the restricting HLA allele. Polymorphisms will include mutations
which disrupt immune surveillance (by altering processing, MHC
binding affinity or T-cell recognition), and compensatory muta-
tions which restore fitness to the virus.
Cohort consensus sequence
For each gene in the HIV-1 genome, all viral amino acid
sequences in the cohort were aligned using TCoffee [76], and the
most frequent amino acid assigned as the cohort consensus. To
obtain the nucleotide consensus, the amino acid sequence was
used as an alignment guide for the program tranalign (available
from http://emboss.sourceforge.net) and the most frequently
occurring triplet of nucleotides coding for the most frequent
amino acid was chosen as the cohort nucleotide consensus.
Number of Escape Events (NEE) calculation
The number of epitopes with a coding change (NEE) was
calculated for each patient, either across all genes, or by separating
the epitopes by gene and calculating a NEE score for each gene.
HLA-matched epitopes, plus flanking regions of 3 amino acids
either side of the epitope, were taken from the K37 HLA-epitope
list and compared to the epitope in the cohort consensus amino
acid sequence. Any deviation from the cohort consensus was
marked as a putative escape mutation and the number of putative
escape events (NEE) calculated. The escape event could have
happened at any time point prior to sampling (i.e. during the acute
or chronic phases, or was already present in the transmitted
infecting virus). The number of escape events per epitope is
capped at one, i.e. if there are two HLA-associated polymorphisms
in the same epitope then this is counted as a single, and not
multiple, escape event.
Number of Synonymous Epitopes (NSE) calculation
We use NSE to quantify the background level of mutations in an
individual. NSE is the equivalent of NEE for synonymous
nucleotide changes. The method for obtaining a score for NSE,
i.e. epitopes with a silent coding change, is similar to the method
for obtaining NEE, save that the individual’s viral nucleotide
sequence is compared with the cohort consensus nucleotide
sequence and only non-coding changes enumerated.
Correcting log viral load for NSE
To calculate the impact of HLA polymorphisms on viral load
after correcting for the ‘‘background’’ number of mutations, we
performed multiple linear regression with log viral load as the
dependent variable and NEE and NSE as predictors:
log(VL){^ b bNSE~aNEE ð4Þ
The data plotted in Figures 2 and 3 are partial residual plots,
that is, they show viral load after removing the background
level of mutation for each individual. The left-hand side of
Equation 4 was plotted on the y-axis against NEE on the x-axis,
where ^ b b is the regression coefficient for NSE from the fitted full
model. The fraction of variation in viral load in the cohort that
could be explained by this model was calculated using the R
2
coefficient.
Frequency of significant positive association between log
viral load and escape events by gene
Patients were selected from the Full cohort at random with
replacement 10,000 times. For each bootstrap iteration in which
total escape events over all genes was a significant predictor of log
viral load, escape events were then split by gene to determine
escape events in which gene were significant predictors of log
viral load. When multiple genes were found to be significant
predictors, we checked if they were independent predictors or
correlated with escape events in other genes. Sets of indepen-
dently significant genes contributing less than 1% of the total runs
are grouped together as ‘‘Minor effects’’ and excluded from
further analysis. Multiple linear regression was used to determine
significance, and the number of synonymous changes was always
included as a co-predictor. See Text S1 for full details of the
method.
Fraction of viral load variation explained by HLA class I
genotype
To estimate the fraction of viral load variable that can be
explained by the HLA class I genotype, we calculated the
‘‘Explained Fraction’’ (EF) metric [61] on data reported by Nelson
et al. [61], Pereyra et al. [33] and Emu et al. [62] separately. We
categorised the various HLA class I genotypes into two classes:
protective alleles and not protective (or susceptible) alleles. Disease
states were categorised either using AIDS endpoints (for the
Table 1. Parameter ranges, descriptions and references for the mathematical model.
Parameter Range Description (units) Reference
l 5–30 Influx of new uninfected CD4
+ cells (c d
21) [65]
d 0.013–0.078 Natural death rate of uninfected CD4
+ cells (d
21) [66]
b 0.001–0.01 Infection rate of wildtype virus (v
21 d
21) [65]
b9 0.001–0.01 Infection rate of variant virus (v
21 d
21) [65]
b 0.5–1.0 Death rate of infected CD4
+ cells from all other sources (d
21) [65,67]
c 0.02–0.2 Death rate of CD4
+ cells by a single CTL clone (d
21) [8,68]
h 20–200 Burst rate of CD4
+ cells infected with wildtype (v c
21 d
21) [69]
h9 20–200 Burst rate of CD4
+ cells infected with variant (v c
21 d
21) [69]
u 3–300 Clearance rate of free virus (d
21) [70,71]
Note that parameter b is the rate of death of infected CD4
+ cells attributable to CTL-independent death and all CTL responses other than the single CTL response which
is escaped (parameter c). Units c: cells mm
23; v: virions mm
23; d: day.
doi:10.1371/journal.pcbi.1000981.t001
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and results are detailed in full in Text S1.
Supporting Information
Figure S1 Comparison of viral loads from the mathematical
model before and after escape. Each line is the log viral load for a
single run from the Attenuated Model, from time zero (before
escape) to the end of the model run (after escape). A small
amount of random noise was added to the x-axis to increase
clarity. Note: 400 of the 10,000 runs were randomly chosen to
represent this graph, as plotting all 10,000 runs resulted in an
incomprehensible figure. The log viral load is significantly lower
after escape (paired t-test: p,0.0001), but the size of the decrease
is small (mean of log difference is 0.09, 95% confidence interval:
0.086–0.10).
Found at: doi:10.1371/journal.pcbi.1000981.s001 (0.06 MB TIF)
Figure S2 Comparison of corrected and uncorrected viral load
with different measures of sequence variation (c.f. Figure 2 in the
main text). Panel A shows the number of escaped epitopes (NEE)
against log viral load, corrected for the number of synonymous
epitopes (NSE), in cohort of 157 HIV-infected individuals as a
graph of points rather than bar graphs. There is a significant
positive correlation between the number of escape events and
NSE-corrected log viral load (multiple linear regression:
p=0.0000139, r
2=0.12). Panel B shows the number of escaped
epitopes (NEE) against log viral load, not corrected for the number
of synonymous epitopes (NSE), in cohort of 157 HIV-infected
individuals. There is a significant positive correlation between the
number of escape events and (uncorrected) log viral load (multiple
linear regression: p=0.026, r
2=0.031). Panel C shows the
number of synonymous epitopes (NSE) against log viral load, in
cohort of 157 HIV-infected individuals. No statistically significant
correlation was found between the number of synonymous
epitopes and viral load (multiple linear regression: p=0.98,
r
2=0.00000274).
Found at: doi:10.1371/journal.pcbi.1000981.s002 (0.24 MB TIF)
Figure S3 Bootstrap analysis of the Full cohort, sampled with
replacement 10,000 times. Panel A shows the distribution of the
one-tailed p-value of NEE as an independent predictor of log viral
load (multiple linear regression: median two-tailed p-value was
0.0019, 95% confidence interval 0.0018–0.0021; the shaded area
shows the proportion of runs where NEE was significant at a one-
tailed p-value of #0.025). Panel B shows the distribution of the p-
value of NSE as an independent predictor of log viral load
(multiple linear regression: median two-tailed p-value was 0.030,
95% confidence interval 0.028–0.031; shaded area shows the
proportion of runs where NSE was significant at a one-tailed p-
value of #0.025). Panel C shows the distribution of the difference
in viral load of each of the runs (median log difference: 0.1097;
95% confidence interval 0.1091–0.1104).
Found at: doi:10.1371/journal.pcbi.1000981.s003 (0.26 MB TIF)
Figure S4 Distribution of one-tailed p-values from multiple
linear regression of each gene in the K37 epitope list. Subjects
were sampled with replacement 10,000 times from the Full cohort
(N=157). The shaded area on the left-hand side of each graph
indicates the proportion of runs with a statistically significant
increase in log viral load (one-tailed p#0.025), and the shaded
area on the right indicates a significant decrease in log viral load
(one-tailed p$0.975). In each panel the median change in viral
load associated with an escape event in that gene is presented. See
Table S3 for the percentage of runs by gene where coding changes
are statistically significant.
Found at: doi:10.1371/journal.pcbi.1000981.s004 (0.35 MB TIF)
Table S1 Descriptions of the mathematical models. In addition
to these models which assumed that the variant virus would always
be attenuated compared to the wildtype, an ‘equal fitness’ version
was run. Here, the variant was assumed to have the same fitness as
the wildtype in the absence of CTL. For these models the infection
(b) and virion production (h) rates were the same for wildtype and
variant virus. Legend. 5D: five population; 6D: six population;
MA: mass action; MM: Michaelis-Menten.
Found at: doi:10.1371/journal.pcbi.1000981.s005 (0.03 MB
DOC)
Table S2 Stratification of the Durban cohort by frequent or
protective alleles. A frequently occurring allele was defined as
occurring in more than 6% of the cohort. An allele was defined as
‘protective’ if the median viral load of all individuals possessing
that allele was lower than the median viral load of the cohort, see
Figure 3 of Kiepiela et al. 2004. For each group, multiple linear
regression was performed to determine whether NEE or NSE were
significant independent predictors of log viral load.
Found at: doi:10.1371/journal.pcbi.1000981.s006 (0.03 MB
DOC)
Table S3 Summary of multiple linear regression on the Full
cohort on log viral load against the number of escaped epitopes
(NEE), stratified by gene. Results which are statistically significant
(two-tailed p,0.05) are shown in bold font.
Found at: doi:10.1371/journal.pcbi.1000981.s007 (0.03 MB
DOC)
Table S4 Breakdown by gene the percentage of times escape
events predicted log viral load. Percentage of the 10,000 bootstrap
runs on the Full cohort where escape events (NEE) in a single gene
were a statistically significant predictor of log viral load,
independent of the number of synonymous changes (NSE). Also,
see Figure S4.
Found at: doi:10.1371/journal.pcbi.1000981.s008 (0.03 MB
DOC)
Table S5 Percentage of the 10,000 bootstrap runs on the Full
cohort where escape events in a gene were a significant
independent predictor of log viral load, stratified by gene and
corrected for the number of synonymous changes (NSE). Where
there was a statistically significant association between NEE in all
genes and log viral load, the genes driving this association were
identified using multiple linear regression, or if none had p-values
under 0.05, the gene with the lowest p-value in the regression was
chosen. N.B. the totals do not sum to 100% as escape events in
multiple genes can be significant independent predictors of log
viral load.
Found at: doi:10.1371/journal.pcbi.1000981.s009 (0.03 MB
DOC)
Table S6 K37 HLA-epitope list. This list is taken from Kiepiela
et al. (2007), Supplementary Table S3, and consists of 37 HLA-
epitopes pairs which are statistically significantly associated with
coding changes in the epitope region (plus three amino acids either
side of the epitope region) in individuals with the same HLA class I
allele.
Found at: doi:10.1371/journal.pcbi.1000981.s010 (0.07 MB
DOC)
Text S1 Supplemental information for alternative mathematical
models and additional methods and results.
Found at: doi:10.1371/journal.pcbi.1000981.s011 (0.24 MB
DOC)
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